The IDIBELL Educational Committee aims to facilitate compliance and make proposals regarding the tasks carried out by the Directorate on aspects related to the training of IDIBELL researchers in order to improve or make amendments to them.<\/p>\n\t\t\t\t\tFunctions<\/a>\n\t\t\t\t\t The IDIBELL Equality and Diversity Management Committee aims to facilitate compliance with current legislation on equality and diversity management issues. In addition to drafting the Equality and Diversity Management Plan, its functions include providing advice to the management on matters related to compliance with equality laws and the evaluation of the institute’s equality indicators.<\/p>\n The Committee members have a commitment to confidentiality, with this body acting as a means to resolve issues related to harassment on the grounds of sex, race, religious beliefs or geographic origin.<\/p>\n\t\t\t\t\tMembers<\/a>\n\t\t\t\t\t\u2022 Ander G\u00f3mez, Management Director Biosafety refers to the collection of measures (organisation, work practices, design of facilities, safety equipment, etc.) aimed at safeguarding and protecting humans, animals, plants and the environment against any and all agents, factors and risks of biological origin.<\/p>\n The main duties of the IDIBELL Biosafety Committee are to evaluate the risk of biosafety for projects initiated in the institution, to support training activities for users of rooms with biosafety levels of 2 or higher, to propose improvements to processes or protocols, and to advise the centre management on all Biosafety matters.<\/p>\n\t\t\t\t\tMembers<\/a>\n\t\t\t\t\t The Works Council is the representative body for workers in the company and defends their interests. Committee members are elected democratically for mandates of 4 years, and the number of representatives is based on the number of workers hired by the company.<\/p>\n\t\t\t\t\tMembers<\/a>\n\t\t\t\t\t In addition, according to the legislation in force, members of the Workers’ Committee must represent workers in the following bodies:<\/p>\n <\/p>\n The Research Ethics Committee with medicines (CRE\/CREm) is committed to safeguarding the rights, safety and wellbeing of human beings taking part in any research projects which may involve physical or psychological risk, and to provide public guarantees, while evaluating the correct conduct of the projects and monitoring their development.<\/p>\n\t\t\t\t\tComposition<\/a>\n\t\t\t\t\t President<\/strong><\/p>\n Dr. Francesc Esteve Urbano \u00b7 Doctor – Intesive Medicine, Bellvitge University Hospital<\/p>\n <\/p>\n Vice president<\/strong><\/p>\n Dra. Pilar Hereu Boher \u00b7 Doctor – Clincal Pharmacology, Bellvitge University Hospital<\/p>\n <\/p>\n Secretary<\/strong><\/p>\n Dr. Adri\u00e0 Domingo Carnice \u00b7 Pharmacist – Hospital Pharmacy, Bellvitge University Hospital<\/p>\n <\/p>\n Vocals<\/strong><\/p>\n Dr. Jordi Adamuz Tom\u00e1s . Nurse – Nursery, Bellvitge University Hospital<\/p>\n Dr. Concepci\u00f3n Ca\u00f1ete Ramos . Doctor -Pneumology, Integral Sanitary Consortium<\/p>\n Dr. Sara Cobo Sacristan Pharmaceutical – Hospital Pharmacy<\/p>\n Dr. Ana Mar\u00eda Ferrer Artola \u00b7 Pharmacist – Health member, Bellvitge University Hospital<\/p>\n Ms. Esther Ferrer Canals – Patient representative<\/p>\n Dr. Xavier Fulladosa Oliveras \u00b7 Doctor – Nefrology, Bellvitge University Hospital<\/p>\n Ms. Sara Hidalgo Dur\u00e1n \u00b7 Phylosophy – Non-health member<\/p>\n Dr. Carles Llad\u00f3 i Carbonell . Doctor – Urology, Hospitalet General Hospital – Integral Sanitary Consortium<\/p>\n Dr. Sara Larriba Bartolom\u00e9 \u00b7 Pharmacist – Health member, Research in Traslational Medicine Area IDIBELL<\/p>\n Ms. S\u00f2nia L\u00f3pez Ortega \u00b7 Social Graduate – Attention to Citizenship, Bellvitge University Hospital<\/p>\n Dr. Juan Jes\u00fas Mart\u00edn Liberal \u00b7 Physician – Medical Oncology<\/p>\n Dr. Sergio Morch\u00f3n Ramos \u00b7 Doctor – Preventive Medicine, Bellvitge University Hospital<\/p>\n Dr. Miguel \u00c1ngel Pav\u00f3n Ribas Biologist – Non-health member<\/p>\n Dr. Jos\u00e9 Carlos S\u00e1nchez Salado \u00b7 Physician – Cardiology<\/p>\n Dr. Abelardo Montero Saez \u00b7 Physician – Internal Medicine<\/p>\n Dr. N\u00faria Calaf Figueres \u00b7 Pharmacist – Primary Care<\/p>\n Dr. Maria Teresa Ter\u00e1n Virtus \u00b7 Physician – Clinical Pharmacology<\/p>\n Dr. Antoni Lorente Mart\u00ednez \u00b7 Engineer – Non-health member<\/p>\n\t\t\t\t\tFunctions<\/a>\n\t\t\t\t\t The CREC is also intended to serve as a reference and provide support to researchers within its areas of competence, in particular guidance on criteria required regarding the methodological, ethical and legal aspects of the projects, as well as with respect to monitoring at the sites involved, within the scope of its action.<\/p>\n To carry out this task, the Committee refers to the main internationally accepted bioethical codes, the Guidelines of Good Clinical Practice (GCP) and current legal regulations, such as Organic Law 3\/2018 on Personal Data Protection and the guarantee of digital rights, General Data Protection Regulation (EU) No. 2016\/679, Organic Law 41\/2002, as regards its general scope, and RD 1090\/2015 on clinical trials with medicines and Law 14\/2007 on Biomedical Research, within the specific regulations, among others.<\/p>\n\t\t\t\t\tAccreditation<\/a>\n\t\t\t\t\t The Committee is accredited by the Directorate General for Healthcare Planning and Regulation of the Department of Health of the Regional Government of Catalonia, in accordance with the provisions of Decree 406\/2006 and Instruction 1\/2017 of the Directorate General for Healthcare Planning and Regulation of the Department of Health. Moreover, the Committee is registered with the Office for Human Research Protections (OHRP) of the U.S. Department of Health and the Human Services Office of the Secretary Office of Public Health and the Science Office for Human Research Protections (HHS), with code IRB00005523 and Federal-wide Assurance Number FWA00010235.<\/p>\n This Committee acts as an external advisory ethics committee for the HUB-ICO-IDIBELL Biobank, in accordance with the provisions of Law 14\/2007 on Biomedical Research and RD 1711\/2016 on Biobanks.<\/p>\n The Ethical Committee for Animal Experimentation of the Bellvitge Biomedical Research Institute (CEEA-IDIBELL) is the body responsible for ensuring the care and welfare of the animals housed in the IDIBELL Animal Facility Service (Registration number B9900010), ensuring the proper functioning of the animal facility and the prevention of occupational hazards within this space. It was approved by the competent authority (Government of Catalonia, May 14, 1998).<\/p>\n\t\t\t\t\tMembers<\/a>\n\t\t\t\t\t Merc\u00e8 Mart\u00ed Gaudes (President)<\/p>\n Teresa Rodrigo Calduch (Vicepresident and external expert)<\/p>\n Rosa Bonavia Abril\u00a0 (Secretary & Animal welfare)<\/p>\n Javier M\u00e1rquez Novales (Administrative support)<\/p>\n Anna Jim\u00e9nez Mauri (Quality)<\/p>\n Beatriz Pinilla Romero (Quality)<\/p>\n Vanessa Cervera Soriano (Contact with CBS)<\/p>\n Juana Fern\u00e1ndez Rodr\u00edguez (Mouse Lab)<\/p>\n Cristina Sant\u00f3n Ramiro (lego Member)<\/p>\n Vocals<\/p>\n The functions of CEEA, in compliance with current legislation and the recommendations of The Guide for the Care and Use of Laboratory Animals are:<\/strong><\/p>\n <\/p>\n In addition, in compliance with the requirements of AAALAC International, CEEA-IDIBELL is responsible for the review of the animal care and use program:<\/strong><\/p>\n The Research Ethics Committee of the extinct Barcelona Regenerative Medicine Center Foundation (CMR [B]) acts today within the functional framework of the Bellvitge Biomedical Research Institute (IDIBELL), maintaining the competencies that were attributed to it by the Additional Provision of Decree 406\/2006, of October 24, which regulates the requirements and the accreditation procedure of clinical research ethics committees.<\/p>\n This committee centralizes the function, with autonomic scope, of evaluating and reporting on projects with stem cells, regardless of the center where they are planned to be carried out. The Regenerative Medicine CEI oversees research projects, ensuring that they are correct from a methodological, ethical and legal point of view, and take into account all possible physical, biological or psychological risks for human beings.<\/p>\n\t\t\t\t\tComposition<\/a>\n Presidency<\/strong><\/p>\n Mar\u00eda Berdasco Men\u00e9ndez, head of the Epigenetic Therapies group at the Josep Carreras Leukemia Research Institute.<\/p>\n <\/p>\n Vice president<\/strong><\/p>\n Carles Miquel Collell, Doctor of Medicine<\/p>\n <\/p>\n Secretary<\/strong><\/p>\n Anuska Linares Baraza, Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL)<\/p>\n <\/p>\n Members<\/strong><\/p>\n Xavier Gibert Espier, Lawyer, Technical Office. Secretaria General del Departament de Salut de la Generalitat de Catalunya.<\/p>\n Pilar Giner Boya, Doctor in Pharmacy. Hospital Pharmacy Specialist.<\/p>\n N\u00faria Sabat\u00e9 Aug\u00e9, Doctor in Pharmacy.<\/p>\n Rafael Rodr\u00edguez Rodr\u00edguez, Nurse and Treasurer – Member of the Spanish Society of Attention to Health Users (SEAUS).<\/p>\n Pilar Hereu Boher – Head of HUB Clinical Pharmacology Service<\/p>\n …- Data protection coordination<\/p>\n\t\t\t\t\tFunctions<\/a>\n 1. Assess the research projects (R&D) and their modifications, in relation to the defined objectives, the scientific evidence and the justification of the foreseeable risks and annoyances for the participants based on the potential benefits.<\/p>\n 2. Evaluate the preparation of the researchers for the proposed project, as well as the suitability of the facilities and equipment available in the center where the R&D project is to be completed.<\/p>\n 3. Evaluate the written information that is provided to both the donors of the biological structures that can be used in research projects, and review the informed consent document that is proposed in each particular case, in order to guarantee full knowledge of what participation entails. Failing that, this information will be delivered to the patient’s legal representative.<\/p>\n 4. Carry out the follow-up of the R&D projects that are in the process of being carried out, by means of the periodic written information that the researchers will send and that will be at least annually until the receipt of the final report.<\/p>\n 5. Be willing to perform those other functions that the Department of Health may assign within your area of \u200b\u200bknowledge, in addition to those already defined in Decree 406\/2006.<\/p>\n 6. Prepare and approve the annual report of activities.<\/p>\n The main mission of the Health and Safety Committee is to ensure the protection of the health and safety of workers in the work environment, ensuring compliance with current regulations and promoting a safe, healthy and sustainable work environment.<\/p>\n\t\t\t\t\tMembers<\/a>\n\t\t\t\t\t Presidency – <\/b>Ander G\u00f3mez (Management director)<\/p>\n Secretary – <\/b>Antonia Gaona (Works Council member and Prevention delegate)<\/p>\n <\/p>\n Members<\/b><\/p>\n Sonia Del Oro (Works Council member and Prevention delegate)<\/p>\n Jose Antonio Castro (Works Council member and Prevention delegate)<\/p>\n Ana Coelho (Head of People Management)<\/p>\n Anna M\u00aa Jim\u00e9nez (Quality Unit technician)<\/p>\n <\/p>\n Guest Advisory Staff<\/strong><\/p>\n Beatriz Calvo – (Head of SPPM ICO-IDIBELL)<\/p>\n Sonia Colome – (SPPM ICO-IDIBELL technician)<\/p>\n\t\t\t\t\tFunctions<\/a>\n\t\t\t\t\t a) Direct supervision:<\/strong> Evaluating the risk prevention situation in the workplace, including carrying out periodic or specific visits or inspections, as deemed necessary.<\/p>\n b) Access to information:<\/strong> Reviewing and accessing all documentation and reports related to working conditions and risk prevention, including those derived from the activity of the prevention service or from other relevant sources.<\/p>\n c) Investigation and analysis:<\/strong> Examining incidents or damages that affect the health or physical integrity of IDIBELL personnel, identifying their causes and formulating specific proposals to implement corrective and preventive measures.<\/p>\n d) Annual monitoring:<\/strong> Knowing, analyzing and reporting on the annual report and programming of prevention services, ensuring that they are available to the competent labor and health authorities.<\/p>\n e) Creation of working groups:<\/strong> Establishing specific commissions or working groups when necessary to address extraordinary issues or complex problems that require detailed evaluation.<\/p>\n The Research Integrity Committee (CIR) is a body constituted, from the Management initiave, by research staff of the center on a free and voluntary basis, aimed at promoting knowledge and internal adoption of the code of good practices. Likewise, the CIR will arbitrate the consultations and conflicts that may arise, and will assist, when necessary, the Ombudsperson.<\/p>\n The CIR acts independently (from the Management), at the service of the IDIBELL research staff who adhere to the IDIBELL’s Guide to Best Practices in Health Sciences Research, with the sole objective of supporting the quality of the research and help preserve its integrity.<\/p>\n\t\t\t\t\tComposition<\/a>\n\t\t\t\t\t\n
\n… (Talent Head)\nMembers<\/strong>
\nCristina Mayordomo ( Scientific Direction)
\nRuth Rodr\u00edguez Barrueco (Oncobell Teaching Coordinator)
\nLaura Costas (Epibell Teaching Coordinator)
\nAna Mendez (Neurobell Teaching Coordinator)
\nCarolina Florian (Regenbell Teaching Coordinator)
\nRa\u00fal Ramos (Translational Medicine Teaching Coordinator)
\nJoan Pera (PhD Committee Representative )\n\n\t\tTBA\n\t<\/h3>\n
\n\t\tCOORDINATOR\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tEDUCATIONAL COMMITTEE\n\t\t\t\t\t<\/a>\n
\n\t\tEquality Plan Monitoring Committee\n\t<\/h3>\n\t
\n\u2022 …, Equality Coordinator
\n\u2022 Vanesa Cervera, CE member
\n\u2022 Antonia Gaona, CE member\n\n\t\tTBA\n\t<\/h3>\n
\n\t\tCOORDINATOR\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT EQUALITY COMMITTEE\n\t\t\t\t\t<\/a>\n
\n\t\tDOCUMENTS\n\t<\/h3>\n
\n\t\t\n\t\tEquality plan\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tProtocol for situations of harassment in the IDIBELL workplace\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tGuide to Non-sexist language\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tBiosafety committee\n\t<\/h3>\n\t
\n
\n\t\tM. Cristina Mayordomo Tella\n\t<\/h3>\n
\n\t\tCOORDINATOR\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT BIOSAFETY COMMITTEE\n\t\t\t\t\t<\/a>\n
\n\t\tDOCUMENTS\n\t<\/h3>\n
\n\t\t\n\t\tINSHT Technical Guide for the evaluation and prevention of risks related to exposure to biological agents\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tRoyal Decree 664\/1997, of 12 May, on the protection of employees against risks related to exposure to biological agents during..\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tWorks Council\n\t<\/h3>\n\t
\n
\n
\n
\n\t\tRa\u00fcl Zamora\n\t<\/h3>\n
\n\t\tPRESIDENT\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT WORKS COUNCIL\n\t\t\t\t\t<\/a>\n
\n\t\t\n\t\t BOE – 2012 Labor reform\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tLaw for the Reconciliation of Work with Family Life\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tResearch Ethics Committee with medicines (CRE\/CREm)\n\t<\/h3>\n\t
\n\t\tAdri\u00e0 Domingo Carnice\n\t<\/h3>\n
\n\t\tTECHNICAL SECRETARY\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT CRE\/CREm\n\t\t\t\t\t<\/a>\n
\n\t\t\n\t\tpresidenciaceic@bellvitgehospital.cat\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tadomingo@idibell.cat\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tLINKS OF INTEREST\n\t<\/h3>\n
\n\t\t\n\t\tResearch Ethics Committee with medicines (CRE\/CREm)\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tGuide for the correct elaboration of a model information sheet for the patient and informed consent\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tEthical Committee for Animal Experimentation\n\t<\/h3>\n\t
\n
\n
\n
\n
\n\t\tMerc\u00e8 Mart\u00ed Gaudes\n\t<\/h3>\n
\n\t\tPRESIDENT\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT CEEA\n\t\t\t\t\t<\/a>\n
\n\t\t\n\t\tCEEA Regulation\n\t\t<\/a>\n\t<\/h3>\n
\n\t\t\n\t\tEjemplos de reeemplazo, reducci\u00f3n y refinamiento desde la SEBBM. Jornada BOARD2022 de EARA.\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tRegenerative Medicine CEI\n\t<\/h3>\n\t
\n\t\tAnuska Linares Baraza\n\t<\/h3>\n
\n\t\tSECRETARY\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT CEI\n\t\t\t\t\t<\/a>\n
\n\t\tLINKS OF INTEREST\n\t<\/h3>\n
\n\t\tMore information on procedures, documentation and meeting dates on the website of the Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C]\n\t<\/h3>\n
\n\t\t\n\t\tp-cmrc.cat\/ethics\/ethics-committee\n\t\t<\/a>\n\t<\/h3>\n
\n\t\tHealth and Safety Committee\n\t<\/h3>\n\t
\n\t\tAnder G\u00f3mez\n\t<\/h3>\n
\n\t\tPRESIDENT\n\t<\/h3>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT CSS\n\t\t\t\t\t<\/a>\n\t\t\t\n\t\t\t\t\t\t\tCONTACT PREVENTION DELEGATES\n\t\t\t\t\t<\/a>\n
\n\t\tResearch integrity committee (CIR)\n\t<\/h3>\n\t
\n